Want to join the conversation?
$FHN said it reported higher earnings in 2Q16, helped by higher net interest income and noninterest income compared to 2Q15. Net income available to common shareholders was $56.54MM or $0.24 per diluted share compared to $50.56MM or $0.22 per diluted share last year. Total revenue grew 8% from a year ago to $321.78MM.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?